Figures & data
Table 1. Demographics and disease type of the HOLISM study population [n (%), unless otherwise stated].
Table 2. Fish consumption and omega 3 supplementation for all respondents and those with relapsing–remitting MS only [n (%)].
Table 3. Disability by omega 3 consumption, type and dose, and frequency of fish consumption for all respondents [n (%)].
Figure 1. HR-QOL outcomes of all respondents by frequency of fish consumption. Groupwise comparisons: all p < 0.001. Pairwise group comparisons: ****p < 0.001, ***p = 0.002, **p = 0.003, *p = 0.013.
Table 4. Significant predictors and covariate for components of HRQOL.
Table 5. Relapse rate (last 12 months rate, 95% CI) and disease activity [n (%)] in those with relapsing–remitting MS by fish consumption, omega 3 supplementation, dose, and type.